معرفی
Maarja Haugas is a Research Fellow at the University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine. She also serves as a Specialist at Tartu University Hospital's Genetics and Personalized Medicine Clinic. Her career spans institutions including University of Helsinki and Quattromed AS, with research focusing on biomedical applications, cancer biology, and developmental neuroscience.
- Doctor's Degree (2011), University of Helsinki: GATA Factors Regulate Inner Ear Development and Midbrain Neurogenesis
- Research Master's Degree (2005), University of Tartu: Gata3 Regulates Placode Morphogenesis and Fgf Signaling
Her research interests integrate Biomedicine, Clinical Biology, and Precision Medicine, with specific expertise in GATA transcription factors, neuronal differentiation, and targeted peptide therapies. Recent publications demonstrate innovation in tumor-targeting peptides, CAR T-cell engineering, and mitochondrial DNA regulation.
- 2025: Cyclic peptide glioblastoma targeting via SNAP25
- 2024: Protease-activated CendR peptides for tumor specificity
- 2023: β1-integrin aptamers for breast cancer therapy
Scientific honors include the 2015 Tartu University Development Fund Award, 2013 University of Helsinki Postdoctoral Position, and 2006 Marie Curie Fellowship.
She contributes to the Estonian Society of Medical Genetics since 2024, with administrative experience in R&D settings. Her work bridges developmental biology, cancer research, and translational medicine through molecular mechanisms and targeted delivery systems.
